Perrigo Company plc (PRGO) stock analysis

PRGO · Perrigo Company plc

Latest recorded price: USD 16.18

Model-estimated fair value: USD 24.76. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic

At $16.18, PRGO trades 34.6% below the model's base-case value of $24.76. Using FCFF DCF, the model estimates $10.12 in the conservative case and $54.68 in the optimistic case, with a valuation confidence score of 80/100. About 80% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth -1.5%, free cash flow margin 3.4%, ROIC -15.3%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare